Research & Development



  話說到了這里,三人就乘坐一輛馬車直奔陽陵邑,準備跟李敢當面把事情說清楚,再糾纏下去,很容易成為心病。   這樣的天氣里,雲氏沒有人喜歡大清早就起來。黄色网站   “我以後遇到這樣的情況怎麼辦?比如張安世一定要拉著我干我不願意干的事情?”色情网站   “本來就不是屬于這個時代的東西。”   紅袖正要呵斥雲音,十歲的大姑娘了,怎麼還說這樣的話。免费的三级黄网站   如果無鹽氏將純度不高的黃金沒有納入私囊,這樣做對陛下是有利的。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo